Annual report pursuant to Section 13 and 15(d)

Income Taxes (Tables)

v3.22.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2021
Income Tax Disclosure [Abstract]  
Schedule of Components of Income Tax Expense (Benefit)
The components of the Company's deferred tax assets and liabilities are as follows:

Year Ended December 31,
(in thousands)
2021 2020
Currently reportable expense
Federal
$ $
State
Deferred benefit:
Federal
6,129 1,841
State
2,163 591
8,292 2,432
Less valuation allowance (8,292) (2,432)
Total provision for income tax expense $ $
Schedule of Deferred Tax Assets and Liabilities
December 31,
(in thousands)
2021 2020
Gross deferred tax assets arising from
Net operating loss carryforwards
$ 11,619 $ 1,990
ASC 842 right-of-use asset and liability
3,661 979
Capitalized SPAC transaction costs
1,207
16,487 2,969
Deferred tax liabilities arising from:
Deferred franchise tax
(598)
         ASC 842 right-of-use asset
(3,071)
Depreciation
(1,714) (156)
Total deferred tax liabilities (5,383) (156)
Net deferred tax assets before valuation allowance 11,104 2,813
Less valuation allowance (11,104) (2,813)
Net deferred tax assets $ $